Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05910268 · ClinicalTrials.gov registry record · NA

Peru Decentralized HIV Care

A NA study of HIV, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
1,450
Enrollment target
2
Study locations

NCT05910268 is a NA study of HIV that is actively recruiting participants, run by Yale University. The registered enrollment target is 1,450 participants, above the 435-participant average among 303 other HIV trials with a reported enrollment target (233% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05910268, a NA study of HIV, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
1,450 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to understand the processes by which HIV care is decentralized, an evidence-informed strategy to improve retention in HIV care, in Peru. Decentralization of HIV services has not been evaluated using experimental designs and urban decentralization studies of HIV are uncommon, so this study will lend important insights for future decentralization efforts in Peru and other countries.

Conditions Studied

Interventions

  • BEHAVIORAL NIATx + ECHO

Study Locations (2)

Connecticut

  • Yale University - New Haven

Other

  • CITBM - Centro de Investigaciones Tecnológicas Biomédicas y Medioambientales - Bellavista

Trial Details

FieldValue
Enrollment Target 1,450 participants
Start Date 2024-04-01
Est. Completion 2028-07-01
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05910268

The ClinicalTrials.gov registry entry for NCT05910268 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 435-participant average among 303 other HIV trials with a reported enrollment target (233% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which NIATx + ECHO is the first listed.

NCT05910268 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Other.

Frequently Asked Questions

What is clinical trial NCT05910268 about?

NCT05910268 is a clinical study titled "Peru Decentralized HIV Care". The purpose of this study is to understand the processes by which HIV care is decentralized, an evidence-informed strategy to improve retention in HIV care, in Peru. Decentralization of HIV services has not been evaluated using experimental designs and urban decentralization studies of HIV are uncom...

What is the current status of trial NCT05910268?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,450 participants. The study started on 2024-04-01. Estimated completion is 2028-07-01.

What conditions does trial NCT05910268 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT05910268?

The interventions under investigation include: NIATx + ECHO (BEHAVIORAL).

Who is sponsoring clinical trial NCT05910268?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05910268 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.